US Stock MarketDetailed Quotes

EWTX Edgewise Therapeutics

Watchlist
  • 17.520
  • +0.040+0.23%
Trading May 14 11:20 ET
1.64BMarket Cap-11376P/E (TTM)

Edgewise Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
35.20%34.75M
59.59%114.36M
53.37%33.86M
61.27%29.45M
53.65%25.34M
73.37%25.7M
65.82%71.66M
72.20%22.08M
39.66%18.26M
57.66%16.49M
Selling and administrative expenses
21.12%7.06M
33.05%23.45M
13.01%6.18M
29.72%5.67M
41.35%5.78M
57.43%5.83M
59.86%17.63M
46.41%5.47M
36.67%4.37M
57.33%4.09M
-General and administrative expense
21.12%7.06M
33.05%23.45M
13.01%6.18M
29.72%5.67M
41.35%5.78M
57.43%5.83M
59.86%17.63M
46.41%5.47M
36.67%4.37M
57.33%4.09M
Research and development costs
39.33%27.69M
68.24%90.91M
66.65%27.68M
71.20%23.79M
57.71%19.56M
78.68%19.88M
67.86%54.03M
82.79%16.61M
40.63%13.89M
57.77%12.4M
Operating profit
-35.20%-34.75M
-59.59%-114.36M
-53.37%-33.86M
-61.27%-29.45M
-53.65%-25.34M
-73.37%-25.7M
-65.82%-71.66M
-72.20%-22.08M
-39.66%-18.26M
-57.66%-16.49M
Net non-operating interest income expense
117.31%6.23M
253.26%14.19M
39.60%3.72M
389.40%3.74M
812.74%3.87M
1,626.51%2.87M
899.50%4.02M
2,014.29%2.66M
501.57%764K
296.26%424K
Non-operating interest income
117.31%6.23M
253.26%14.19M
39.60%3.72M
389.40%3.74M
812.74%3.87M
1,626.51%2.87M
899.50%4.02M
2,014.29%2.66M
501.57%764K
296.26%424K
Other net income (expense)
Income before tax
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-57.99%-67.64M
-52.92%-19.42M
-35.13%-17.5M
-55.19%-16.07M
Income tax
Net income
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-57.99%-67.64M
-52.92%-19.42M
-35.13%-17.5M
-55.19%-16.07M
Net income continuous Operations
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-57.99%-67.64M
-52.92%-19.42M
-35.13%-17.5M
-55.19%-16.07M
Minority interest income
Net income attributable to the parent company
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-57.99%-67.64M
-52.92%-19.42M
-35.13%-17.5M
-55.19%-16.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-57.99%-67.64M
-52.92%-19.42M
-35.13%-17.5M
-55.19%-16.07M
Basic earnings per share
8.33%-0.33
-24.60%-1.57
-56.67%-0.47
-20.59%-0.41
-6.25%-0.34
-20.00%-0.36
-10.53%-1.26
-25.00%-0.3
-30.77%-0.34
-52.38%-0.32
Diluted earnings per share
8.33%-0.33
-24.60%-1.57
-56.67%-0.47
-20.59%-0.41
-6.25%-0.34
-20.00%-0.36
-10.53%-1.26
-25.00%-0.3
-30.77%-0.34
-52.38%-0.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 35.20%34.75M59.59%114.36M53.37%33.86M61.27%29.45M53.65%25.34M73.37%25.7M65.82%71.66M72.20%22.08M39.66%18.26M57.66%16.49M
Selling and administrative expenses 21.12%7.06M33.05%23.45M13.01%6.18M29.72%5.67M41.35%5.78M57.43%5.83M59.86%17.63M46.41%5.47M36.67%4.37M57.33%4.09M
-General and administrative expense 21.12%7.06M33.05%23.45M13.01%6.18M29.72%5.67M41.35%5.78M57.43%5.83M59.86%17.63M46.41%5.47M36.67%4.37M57.33%4.09M
Research and development costs 39.33%27.69M68.24%90.91M66.65%27.68M71.20%23.79M57.71%19.56M78.68%19.88M67.86%54.03M82.79%16.61M40.63%13.89M57.77%12.4M
Operating profit -35.20%-34.75M-59.59%-114.36M-53.37%-33.86M-61.27%-29.45M-53.65%-25.34M-73.37%-25.7M-65.82%-71.66M-72.20%-22.08M-39.66%-18.26M-57.66%-16.49M
Net non-operating interest income expense 117.31%6.23M253.26%14.19M39.60%3.72M389.40%3.74M812.74%3.87M1,626.51%2.87M899.50%4.02M2,014.29%2.66M501.57%764K296.26%424K
Non-operating interest income 117.31%6.23M253.26%14.19M39.60%3.72M389.40%3.74M812.74%3.87M1,626.51%2.87M899.50%4.02M2,014.29%2.66M501.57%764K296.26%424K
Other net income (expense)
Income before tax -24.90%-28.53M-48.08%-100.16M-55.26%-30.14M-46.95%-25.71M-33.62%-21.47M-55.78%-22.84M-57.99%-67.64M-52.92%-19.42M-35.13%-17.5M-55.19%-16.07M
Income tax
Net income -24.90%-28.53M-48.08%-100.16M-55.26%-30.14M-46.95%-25.71M-33.62%-21.47M-55.78%-22.84M-57.99%-67.64M-52.92%-19.42M-35.13%-17.5M-55.19%-16.07M
Net income continuous Operations -24.90%-28.53M-48.08%-100.16M-55.26%-30.14M-46.95%-25.71M-33.62%-21.47M-55.78%-22.84M-57.99%-67.64M-52.92%-19.42M-35.13%-17.5M-55.19%-16.07M
Minority interest income
Net income attributable to the parent company -24.90%-28.53M-48.08%-100.16M-55.26%-30.14M-46.95%-25.71M-33.62%-21.47M-55.78%-22.84M-57.99%-67.64M-52.92%-19.42M-35.13%-17.5M-55.19%-16.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -24.90%-28.53M-48.08%-100.16M-55.26%-30.14M-46.95%-25.71M-33.62%-21.47M-55.78%-22.84M-57.99%-67.64M-52.92%-19.42M-35.13%-17.5M-55.19%-16.07M
Basic earnings per share 8.33%-0.33-24.60%-1.57-56.67%-0.47-20.59%-0.41-6.25%-0.34-20.00%-0.36-10.53%-1.26-25.00%-0.3-30.77%-0.34-52.38%-0.32
Diluted earnings per share 8.33%-0.33-24.60%-1.57-56.67%-0.47-20.59%-0.41-6.25%-0.34-20.00%-0.36-10.53%-1.26-25.00%-0.3-30.77%-0.34-52.38%-0.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg